Sastry Amit, Sulzer Jesse K, Passeri Michael, Baker Erin H, Vrochides Dionisios, McKillop Iain H, Iannitti David A, Martinie John B
Carolinas Medical Center, Charlotte, NC, USA.
Surg Innov. 2019 Dec;26(6):668-674. doi: 10.1177/1553350619855282. Epub 2019 Jun 19.
Hepatic resection presents unique surgical challenges to reduce blood loss during parenchymal division. The development of saline-coupled bipolar devices, in which hemostasis is achieved at lower temperatures than electrocautery or other bipolar sealing devices, have been employed for open hepatic resection. Saline-coupled bipolar devices have now become available for minimally invasive use. The goals of this study were to evaluate the feasibility and safety of a laparoscopic saline-coupled bipolar device for minimally invasive hepatectomy. Seventeen patients (median age 66 years, range 36-81) were consented for inclusion and enrolled. Patient demographics, intraoperative data, and surgeon feedback were collected. Seven robot-assisted partial hepatectomies, 9 laparoscopic partial hepatectomies, and 1 laparoscopic cholecystectomy with liver abscess resection were performed. Average operating time was 222 ± 33 minutes (median 188 minutes; range 61-564 minutes) with no difference between robotic versus laparoscopic time. Successful seals were achieved in all cases following application of 150 to 200 J energy (average 179 ± 3 J, average time to achieve a successful seal 9.3 ± 2.7 minutes). Estimated blood loss was 362 ± 74 mL (median 300 mL, range 5-1200 mL) and 3/17 patients received intraoperative blood transfusion. No bile leaks were detected in any of the patients. Median length of stay was 5 days (range 1-20 days), and there were no readmissions within 30 days. Postoperative morbidity occurred in 5/17 patients, all of which were Clavien Grade 1. There was no mortality within 90 days or complications requiring a return to the operating room, and there were no liver-specific morbidities. These data suggest the laparoscopic Aquamantys device represents a useful device for use in minimally invasive liver resection.
肝切除术在肝实质离断过程中减少失血方面面临独特的手术挑战。盐水耦合双极设备的出现,其止血温度低于电灼或其他双极密封设备,已被用于开放性肝切除术。盐水耦合双极设备现已可用于微创操作。本研究的目的是评估腹腔镜盐水耦合双极设备用于微创肝切除术的可行性和安全性。17例患者(中位年龄66岁,范围36 - 81岁)同意纳入并登记。收集了患者的人口统计学资料、术中数据和外科医生的反馈。进行了7例机器人辅助部分肝切除术、9例腹腔镜部分肝切除术和1例腹腔镜胆囊切除术加肝脓肿切除术。平均手术时间为222±33分钟(中位时间188分钟;范围61 - 564分钟),机器人手术时间与腹腔镜手术时间无差异。在施加150至200焦耳能量(平均179±3焦耳,成功密封的平均时间9.3±2.7分钟)后,所有病例均成功密封。估计失血量为362±74毫升(中位值300毫升,范围5 - 1200毫升),17例患者中有3例接受了术中输血。所有患者均未检测到胆漏。中位住院时间为5天(范围1 - 20天),30天内无再次入院情况。17例患者中有5例发生术后并发症,均为Clavien 1级。90天内无死亡病例,也无需要返回手术室处理的并发症,且无肝脏特异性并发症。这些数据表明,腹腔镜Aquamantys设备是用于微创肝切除术的一种有用设备。